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The immediate cause of the occurrence of cataract is unknown, but oxidative damage and eﬀects of reactive oxygen species
are considered important in its etiopathogenesis. Our research was aimed at testing the nonenzyme antioxidant power of
corticonuclear lens blocks, with diﬀerent types and diﬀerent maturity of age-related cataract. Clinical and biochemical researches
were carried out in 101 patients with age-related cataract. In corticonuclear lens blocks of the patient, the concentration of
nonprotein and total-SH groups and the concentration of total vitamin C and dehydroascorbic acid (DHA) were determined;
the current redox balance of dehydroascorbate/ascorbate and total antioxidant power measured by ferric-reducing ability were
examined. In corticonuclear lens blocks with incipient cataract a signiﬁcantly higher concentration of GSH, total SH groups,
concentration of total vitamin C and ascorbic acid (AA), and ferric-reducing ability were measured. The measured concentration
of DHA is higher than the concentration of AA in the lenses with the incipient and mature cataract. The concentration ratio of
redox couple DHA/AA is higher in lenses with mature cataract, where the measured concentration of AA was lower than in the
incipient cataract. Timely removal of DHA from the lens is important because of its potential toxicity as an oxidant. An increase
of the current concentration of DHA/AA redox balance can be an indicator of oxidative stress.
1.Introduction
Oxidative stress has been implicated in the etiology of a
large number of human long-term degenerative diseases
including cataract. The free radicals that damage cellular
macromolecules, producing oxidative stress, are scavenged
in the human body by a range of antioxidant enzymes
and small-molecule antioxidants. The balance between the
production and catabolism of oxidants by cells and tissue
is essential for the maintenance of the biologic integrity of
the tissue. Ocular tissues contain antioxidants that prevent
damage from excessive oxygen metabolites: antioxidant
enzymes, proteins, ascorbic acid, glutathione, amino acids
(cysteine and tyrosine), uric acid, and others. The fact that
the incidence of cataract is higher in the population that is
more exposed to sunlight [1, 2] imposes the assumption that
photocatalytic conversion of molecular oxygen from ground
state to excited states, which are highly reactive (superoxide
anion (O
•−
2 ), hydrogen peroxide (H2O2), hydroxyl radical
(OH•), and others), occurs. However, despite the possibility
of continuous production of these reactive molecular species
in the aqueous humour and lens due to the continuous
penetration of sunlight during the visual process, a latent
p e r i o do fd e v e l o p m e n to fc a t a r a c ti sl o n g .T h er o l eo f
ascorbate is important, as an eﬀective scavenger of hydroxyl
and superoxide anion radical. High concentration of ascor-
bate in the aqueous humour is assumed to represent a
kind of ﬁlter that prevents the penetration of UV light in
the lens and thus protects tissue from oxidative damage,
particularly photo-induced damage [3]. Diurnal animals
have the highest concentrations, with the ascorbic acid
concentration in some ocular tissues being 20–70 times
higher than in plasma. Maintenance of high concentrations
of vitamin C in the ocular structures is carried out by active
transport from plasma through the barrier blood-aqueous
humour. It is assumed that vitamin C is transported into
the aqueous humour in an oxidized form as dehydroascorbic
acid and then converted to a reduced form, by the eﬀect
of dehydroascorbate reductase in the presence of reduced
glutathione (GSH) mainly in the lens. Since epithelial cells2 Oxidative Medicine and Cellular Longevity
of the ciliary body contain NADPH+H+ and GSH, which are
necessaryforthereductionofdehydroascorbate,itisbelieved
that the conversion of dehydroascorbate to ascorbate is also
done during the transport. This reduction of DHA to less
diﬀusible AA contributes to “retention” of ascorbate in the
lens. Vitamin C in the ocular structures functions through
ascorbate-dehydroascorbateredoxsystem,whichcontributes
tomaintenanceofreducedformsofpyridinenucleotidesand
maintenance of reduced glutathione. In the lens, the ascorbic
acidpreventscationpumpsdamageinducedbyUVradiation
and reduces photoperoxidation in the membranes [4].
Tripeptide glutathione is present in high concentration
in the lens, mainly in reduced form (GSH) [5]. Glutathione
with ascorbic acid in the lens has many functions: it protects
thiol groups of lens proteins against oxidation agents, it is
necessary for the function of glutathione-peroxidase (which
neutralizes reactive oxygen species), it is involved in detox-
iﬁcation of hydrophobic substances in reactions catalysed
by glutathione S-transferase enzymes. Proteins containing
thiol groups are important for normal function of the lens
epithelium, that is, enzyme Na-K-ATP-ase, which aﬀect cell
permeability. Lens membrane is impermeable for GSH, but
itispermeabletoitsoxidizedform(GSSG),whichhasconse-
quently low concentration in the lens. Reduced glutathione,
glutathione peroxidase (GPx), glutathione reductase (GR),
and NADPH+ +H + form antioxidant system of glutathione,
in which GR and NADPH+ +H + are necessary for reduction
of oxidized glutathione and GSH regeneration. Ratio of
GSH/GSSG is normally high in the lens thanks to the
glutathione redox cycle, which is localized in the lens
epithelium and superﬁcial cortex [6].
Aim. Testing of nonenzyme antioxidant power of corticonu-
clear lens blocks, with diﬀerent types and varying maturity
degrees of age-related cataract, by determining the concen-
tration of nonprotein and total SH groups, concentration of
total vitamin C and dehydroascorbic acid and examining the
actual redox couple dehydroascorbate/ascorbate, and total
antioxidantpowerofthelensbymeasuringitsferricreducing
ability.
2.MaterialandMethods
Lens-Reduced Glutathione (GSH) Assay. To determine lens
GSH, 0.2mL of the sample was added directly into tubes
containing 0.2mL of 1mol/L perchloric acid supplemented
with 2mmol/L of disodium EDTA, vortex-mixed, and
centrifuged for 5min at 10000g (4◦C) to remove the protein
precipitate. Lens GSH was determined in a clear supernatant
usingEllman’sreagent[7].0.2mLofthissupernatant,0.8mL
of 0.3mmol/L Na2HPO4,a n d0 . 2 m Lo f5 , 5  -dithiobis-
2nitrobenzoic acid in 1% sodium citrate were added in
succession. The intensity of the resulting yellow colour was
read spectrophotometrically at 410nm.
Lens Total Sulfhydryl Groups (TSH) Assay. Lens total sulfhy-
dryl groups (TSH) were determined using Ellman’s reagent
without prior deproteinization [8].
Total Vitamin C (Ascorbic Acid and Dehydroascorbic Acid)
Assay. The concentration of total vitamin C was deter-
mined by using the method of 2,4-dinitrophenylhydrazine
[9], which in acidic environment builds up coloured bis-
2,4-dinitrophenylhydrazine of ascorbic acid. This method
determines the concentration of total vitamin C, in the form
of ascorbate and dehydroascorbate, and then in coloured
reaction at the same time it determines the existing and
subsequently formed dehydroascorbate. Protein samples
are removed by adding a fourfold volume of 0.61mol/L
trichloroacetic acid, and coloured reaction is performed
with 1.2mL of the supernatant in the presence of 0.4mL
DTBS reagent (32.85mmol/L thiourea, 1.88mmol/L cop-
per sulphate, 90mmol/L 2,4-dinitrophenylhydrazine, and
4.5mol/L sulphuric acid). After incubation for 180 minutes
at 37◦C, the samples are cooled for 10 minutes on ice,
2mL of 12mol/L sulphuric acid is added to each of them,
and absorbance of coloured product is read at λ = 520nm
against a reagent blank, which contains trichloroacetic acid
instead of supernatant sample. In the same way standards of
vitamin C were analyzed (freshly prepared aqueous solutions
of ascorbic acid concentration of 180–240μmol/L).
Dehydroascorbic Acid (DHA) Assay. Dehydroascorbic acid
concentration in the sample was determined by the same
method, with the omission of copper sulphate solution in
DTBS reagent, and the ascorbate (AA) concentration was
calculated from the diﬀerence between total vitamin C and
DHA.
The Ferric Reducing Ability of Lens (FRAL) Assay. The ferric
reducingabilityoflens(FRAL)assaywasusedfordetermina-
tionofantioxidantpowerinlens:atlowpH,whenaferrictri-
pyridyltriazine (Fe+3-TPTZ) complex is reduced to the
ferrous (Fe+2-TPTZ) form, an intense blue color with an
absorptionmaximumat593nmdevelops[10].ReagentPrep-
aration. Reagents included 300mmol/L acetate buﬀer,
pH 3.6; 10mmol/L TPTZ (2,4,6-tripyridyl-s-triazine) in
40mmol/L HCL; 20mmol/L FeCl3·6H2O. Working FRAL
reagent was prepared as required by mixing 25mL acetate
buﬀer, 2.5mL TPTZ solution, and 2.5mL FeCl3·6H2Os o l u -
tion. Aqueous solutions of known Fe (II) concentration, in
the range of 100–1000μmol/L (FeSO4·7H2O), were used for
calibration.
2.1. Patients. Clinical and biochemical researches were car-
ried out in 101 patients with age-related cataract (ARC), 46
women and 55 men. The average age of the group was 72.5
(SD ± 7.98). According to the cataract maturity degree, the
patients were classiﬁed into two groups: age-related cataract
incipiens (N = 41) and matura (N = 60).
Samples of lens corticonuclear blocks were obtained
from patients undergoing extracapsular extraction of age-
related cataracts and used as the test material. Types of
cataract were estimated during ophthalmologic examination
and conﬁrmed during its extraction.
Immediately after sample acquisition, samples were
closedinindividualcapsulesanddeeplyfrozen.ThisresearchOxidative Medicine and Cellular Longevity 3
Table 1: Nonenzymatic antioxidative defense factors in cataractous
lenses.
Age-related
cataract incipiens
(n = 41)
Age-related
cataract matura
(n = 60)
GSH(μmol/g lens) 2.6 ± 0.9 0.9 ± 0.3∗
TSH(μmol/g lens) 102.5 ± 25.5 54.8 ± 19.7∗
Total vitamin C
(μmol/mg lens) 0.61 ± 0.19 0.46 ± 0.16∗
AA (μmol/mg lens) 0.19 ± 0.07 0.11 ± 0.04∗
DHA (μmol/mg lens) 0.41 ± 0.13 0.38 ± 0.13
D/A 2.3 ± 0.6 3.4 ± 0.7∗
FRAL(μmol/g lens) 4.0 ± 1.3 1.4 ± 0.4∗
Data is presented as means ± SD ∗P<0.001. GSH—Glutathione reduced
TSH—Total-SH group AA—Ascorbic acid DHA—dehydroascorbic acid
D/A—Dehydroascorbicacid/ascorbicacidFRAL—Ferric-reducingabilityof
lens.
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Figure 1:LenstotalvitaminCandFRALrelationshipinage-related
cataract.
hasbeenconductedfollowingthetenetsoftheDeclarationof
Helsinki and approved by the ethics committee of Medical
Faculty. Informed consent was provided from all patients
after a careful explanation of the aims of the study.
Sample Collection and Preparation. The wet weight of
the lens corticonuclear blocks was recorded (gr). The lenses
corticonuclear blocks from each group were homogenized
in 10 times their mass of cold 0.2mol potassium phosphate
buﬀer (pH 7.2) supplemented with 137mmol/L KCl and
60mmol/L sodium dodecyl sulfate. The water-insoluble
material was removed by centrifuging for 20 minutes at
12000g (4◦C).
2.2. Statistical Analysis. Values were expressed as means ±
SD. A comparison between groups was performed by Stu-
dent’s t-test and Mann-Whitney U-test. Correlation analysis
was accomplished via calculation of Pearson’s coeﬃcient.
3. Results
By analyzing measured concentrations, signiﬁcantly higher
concentrations of GSH (P<0.001) and total SH groups
(P<0.001) were found as well as signiﬁcantly higher ferric
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Figure 2: Lens ascorbic acid and FRAL relationship in age-related
cataract.
reducing ability (P<0.001) in corticonuclear lens blocks
with incipient cataract (Table 1).
Average measured concentrations of total vitamin C
and dehydroascorbate in homogenate of cataract lenses are
shown in the Table 1. Testing the diﬀerence, depending on
the maturity degree of the cataract, a signiﬁcantly higher
concentration of total vitamin C (P<0.001) was found in
the lenses with the incipient cataract. Measured concentra-
tions of dehydroascorbate in lenses do not diﬀer depending
on the maturity degree of cataract (P = 0.250). The con-
centrationofascorbateobtainedfromthediﬀerencebetween
the total concentration of vitamin C and dehydroascorbate
is signiﬁcantly higher in lenses with incipient cataract (P<
0.001). In order to assess participation of vitamin C in
antioxidant protection of the lens, the concentration ratio
of dehydroascorbate/ascorbate (DHA/AA) was determined,
and signiﬁcantly higher values of DHA/AA ratio (P<0.001)
were found in lenses with mature cataract (Table 1). By
examining the relation between the concentration of total
vitamin C and ferric reducing ability of the lens, we found
a signiﬁcant positive correlation (r = 0.683, P<0.001)
(Figure 1) between the concentration of ascorbate (AA) and
ferric-reducing ability of the lens (r = 0.780, P<0.001)
(Figure 2), between the concentration of GSH and ferric-
reducing ability of the lens (r = 0.804, P<0.001) (Figure 3),
and between the total SH groups and ferric-reducing ability
of the lens (r = 0.726, P<0.001) (Figure 4).
Multiple regression analysis examined the participation
of certain antioxidants in the total antioxidant activity
lens (FRAL) with age-related cataract. The model includes
biochemical parameters of GSH, T-SH, AA, DHA, and
D/A, which explained 82.1% variance values FRAL tested
multiple regression analysis. Signiﬁcant unique contribution
to prediction of FRAL gives ascorbate (AA) (β = 0.358,
P<0.01) and GSH (β = 0.484, P<0.001), (Table 4).
By analyzing the relation between concentrations of total
vitamin C and GSH, signiﬁcant positive correlation (r =
0.410, P<0.001) was determined (Figure 5), as well as
between concentrations of ascorbic acid (AA) and TSH
groups in the lens (r = 0.542, P<0.001) (Figure 6).
The concentration of nonprotein and total SH groups in
corticonuclear lens blocks with diﬀerent types of incipient4 Oxidative Medicine and Cellular Longevity
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Figure 3: Lens GSH and FRAL relationship in age-related cataract.
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Figure 4: Lens T-SH and FRAL relationship in age-related cataract.
Table 2: Nonenzymatic antioxidative defense factors in lenses with
cataract incipiens.
Cataract incipiens
(type)
PS
(n = 23)
NP
(n = 9)
CN
(n = 9)
GSH (μmol/g lens) 3.0 ± 0.9 2.2 ± 0.6∗ 1.8 ± 0.4∗∗
TSH (μmol/g lens) 114.2 ± 26.3 89.2 ± 18.6∗ 85.8 ± 10.8∗∗
Total vitamin C
(μmol/mg lens) 0.64 ± 0.2 0.52 ± 0.17 0.61 ± 0.15
AA (μmol/mg lens) 0.2 ± 0.08 0.16 ± 0.06 0.09 ± 0.19
DHA (μmol/mg lens) 0.44 ± 0.14 0.36 ± 0.13 0.41 ± 0.11
D/A 2.3 ± 0.7 2.3 ± 0.6 2.2 ± 0.6
FRAL (μmol/g lens) 4.5 ± 1.2 3.6 ± 1.2 3.4 ± 0.5∗
Data is presented as means ± SD, ∗P<0.05, ∗∗P<0.01. PS—Posterior
subcapsular NP—Nuclear subcapsular CN—Cortical nuclear.
cataract is presented in Table 2. GSH and total SH groups
concentration is higher in lenses with posterior subcapsular
in relation to nuclear subcapsular cataract (P<0.05) and
in lenses with posterior subcapsular in relation to incipient
corticonuclear cataract (P<0.01).
Estimation of total antioxidant ability of corticonuclear
lens blocks with incipient cataract was performed by FRAL
analysis. Testing the diﬀerence of obtained values, a signif-
icantly higher ferric-reducing ability was found in lenses
with subcapsular cataract than in lenses with corticonuclear
cataract (P<0.05), (Table 2).
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Figure 5: Lens GSH and total vitamin C relationship in age-related
cataract.
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Figure 6: Lens GSH and ascorbic acid relationship in age-related
cataract.
Since the total antioxidant activity is determined by
FRAL analysis, the concentration ratio between some antiox-
idant protection factors and total antioxidant ability of
sample in lenses with incipient cataract was examined. By
examining the correlation ratio between the concentrations
of total vitamin C and ferric-reducing ability in lenses with
incipient cataract, a signiﬁcant positive correlation (r =
0.743, P<0.001) was found also between the concentration
of ascorbate and values of FRAL (r = 0.621, P<0.001),
between nonprotein thiol concentration and ferric-reducing
ability of lenses (r = 0.420, P<0.01), and between the
concentration of total SH and values of FRAL (r = 0.334,
P<0.05).
Average measured concentrations of total vitamin C
and dehydroascorbate in corticonuclear lens blocks with
incipientcataractarepresentedinTable 2.Theconcentration
of ascorbate in the same samples was calculated from the
diﬀerence between concentrations of total vitamin C and
dehydroascorbate, and in order to estimate the participation
of vitamin C in antioxidant protection of lenses with
incipient age-related cataract, the concentration ratio of
dehydroascorbate/ascorbate was determined.
By analyzing the variances, it was determined that
lenses with diﬀerent types of incipient cataract do not
diﬀer in concentration of total vitamin C (P = 0.246),Oxidative Medicine and Cellular Longevity 5
Table 3: Nonenzymatic antioxidative defense factors in lenses with cataract matura.
Cataract matura
(type)
Age-related cataract
matura began as PS
(N = 19)
Age-related cataract
matura began as NP
(N = 15)
Age-related cataract
matura began as CN
(N = 16)
GSH (μmol/g lens) 1.0 ± 0.2 0.8 ± 0.2 0.8 ± 0.3
TSH (μmol/g lens) 59.9 ± 16.6 58.0 ± 20.8 48.2 ± 21.9
Total vitamin C
(μmol/mg lens) 0.49 ± 0.18 0.43 ± 0.19 0.44 ± 0.07
AA (μmol/mg lens) 0.12 ± 0.05 0.1 ± 0.04 0.1 ± 0.02
DHA (μmol/mg lens) 0.37 ± 0.14 0.33 ± 0.15 0.44 ± 0.07∗
D/A 3.4 ± 0.8 3.4 ± 0.7 3.5 ± 0.6
FRAL (μmol/g lens) 1.6 ± 0.5 1.4 ± 0.5 1.2 ± 0.2∗
Data is presented as means ± SD, ∗P<0.05. PS—posterior subcapsular NP—nuclear subcapsular CN—cortical nuclear.
Table 4: Multiple regression analysis.
Variable SE β P
FRAL (μmol/g lens) 0.153
GSH (μmol/g lens) 0.103 0.484 <0.001∗
TSH (μmol/g lens) 3.123 0.107 0.156
AA (μmol/mg lens) 0.007 0.358 0.008∗
DHA (μmol/mg
lens) 0.014 0.11 0.272
D/A 0.091 −0.051 0.617
dehydroascorbate (P = 0.348), ascorbate (P = 0.267), and
concentration ratio of DHA/AA (P = 0.955) (Table 2).
Average measured concentrations of nonprotein and
total thiols, as well as their diﬀerences in lenses with mature
age-related cataract which started in diﬀerent ways, are
shown in Table 3. By analyzing the variances, no signiﬁcant
diﬀerence in concentrations of GSH (P = 0.111) was found,
or the diﬀerence of total thiols (P = 0.268) in lenses with
mature age-related cataract, depending on type that cataract
started with.
By testing diﬀerences of ferric reducing ability of exam-
ined lenses, a signiﬁcantly higher ferric-reducing activity was
found in lenses with mature cataract started as subcapsular
as compared to lenses in which the cataract started as
corticonuclear (P<0.05) (Table 3).
By examining the relation, concentration of total vitamin
C and ferric-reducing ability of lenses with mature cataract,
was found a positive correlation (r = 0.728, P<0.001)
between the concentration of ascorbate and ferric-reducing
ability of lenses (r = 0.679, P<0.001) and between the
concentration of total thiol groups and FRAL values (r =
0.296, P<0.05).
Average measured concentrations of total vitamin C and
dehydroascorbate in lenses with mature cataract, and their
diﬀerences among lenses in which the cataract started in
diﬀerent ways, are shown in Table 3. By analysing variances,
no signiﬁcant diﬀerence in concentration of total vitamin
C( P = 0.582) and ascorbate (P = 0.397) was found, as
well as ratio of DHA/AA (P = 0.913) in lenses with mature
cataract,dependingonhowthecataractstarted.Signiﬁcantly
higher concentration of dehydroascorbate was measured in
lenses where the cataract started as corticonuclear, compared
to lenses where the cataract started as subcapsular-nuclear
(P<0.05), (Table 3).
4. Discussion
Vitamin C has not only antioxidant, but also prooxidant
properties. In which direction will vitamin C work, depends
on the concentration of vitamin C, oxygen and the presence
of metal ions. Oxidation is the cause of modiﬁcation of
lens proteins which accumulate over a lifetime [11]. These
modiﬁcations lead to the formation of molecular aggregates
with high molecular weight causing light scattering, which
is a characteristic of cataract. Some believe that ascorbate
can contribute to protein modiﬁcations, react as prooxidant,
and participate in reactions that generate radicals. These
reactionsmaybecausedbylightormetal-catalyzedoxidation
of endogenous ascorbic acid. It is known that copper and
iron are present in micromolar concentrations and that
autooxidative processes can occur in the lens. In the presence
of metals, especially iron and copper, and oxygen, ascor-
bic acid is oxidized to dehydroascorbate, which produces
hydrogenperoxide,andmetalisreduced.Hydrogenperoxide
can react with reduced metal, generating hydroxyl radical
and other reactive oxygen radicals [4]. When copper and
protein-bound iron is included in this reaction, the radicals
cause oxidative modiﬁcation of amino acids that are near
the metal. These reactions become important when cells
lose their ability to remove metals, making it available for
reaction,and/orwhencellslosetheirabilitytomaintaintheir
vitaminCinareducedform.Itisnotedthatduringtheaging
of lens, as in cataract lenses, the concentration of copper and
iron increases [12]. The data that conﬁrm the level of iron
and copper ions is lower in noncataract lenses, suggesting
that metal ions that mediate the production of HO•,m a yb e
important in the development of age-related cataract [13].
Reaction of lens proteins with ascorbic acid in vitro, in
presence of metals (copper or iron), induces protein mod-
iﬁcations that have been also observed on cataract lenses.
Ascorbate forms covalent bonds with crystalline lens, which
reduces the solubility of proteins [14, 15]. This indicates6 Oxidative Medicine and Cellular Longevity
the potential role of ascorbic acid in the lens proteins
modiﬁcation during the development of cataract. However,
these reactions occur when factors that cause oxidative
damage overcome the capacity of antioxidant mechanisms
of altered metabolism of metal or when the maintenance
mechanism of reduced form of ascorbic acid is compressed.
Analyzing the measured concentration of GSH in lenses
of our patients with age-related cataract, signiﬁcantly lower
concentrations of GSH were found in lenses with mature
cataract (0.9 ± 0.3μmo/g) (P<0.001) than those in lenses
with incipient cataract (2.6 ± 0.9μmo/g). These results are
consistent with the results of other researchers who showed
that the level of reduced glutathione in the lens decreases
with the development of cataract [16, 17], and that with
cataract progression towards the mature, the activity of
glutathione reductase and NADPH+H+-dependent enzymes
of pentose-phosphate pathway is decreased. Reduction of
concentration of GSH in cataract lenses occurs for several
reasons, probably as a result of intense oxidation processes
and formation of toxic products of lipid peroxidation [18–
20]ononehand,comparedtoaweakenedantioxidantcapac-
ity of cataractlenses, on the other. As the main representative
of nonprotein thiols, GSH is included and used in oxidore-
duction processes in conditions of excess oxidized substrates.
It is possible that during oxidative stress GSH is converted
to an oxidized form, which further conjugates with thiol
groups (structural and membrane) proteins, thus reducing
the amount of hydrosoluble proteins in the lens and the lens
turbidity [6]. Other researchers have shown that in cataract
lenses signiﬁcant amounts of GSH are bound with protein
thiols by disulphide bridges where the mixed disulﬁdes of
protein-S-S-GSH (PSSG) type are formed [21]. The reasons
that lead to the conjugation of nonprotein thiols with pro-
teins are insuﬃciently known and in order to come to know
them, the researchers conducted animal lens studies. Thus,
exposure of rat lenses to higher concentrations of hydrogen
peroxide caused a reduction of GSH concentration and an
increase of the amounts of protein-S-S-GSH products. These
changes were accompanied by a reduction of the concentra-
tion of hydrosoluble proteins, increase of amount of protein
insoluble in water, and occurrence of lens turbidity [22].
A possible reason for an amount of reduced glutathione
inthelensesofpatientswithage-relatedcataractisthelackof
hexose monophosphate shunt, responsible for the synthesis
of NADPH+ +H +, which is necessary for the function
of glutathione reductase [5]. Glutathione reductase (GR)
reduces oxidized glutathione (GSSG) to glutathione (GSH)
with electrons donated from reduced form of nicotinamide-
adenine dinucleotide phosphate (NADPH+ +H +) allowing
GSH to protect protein thiols from oxidative damage and
prevent protein cross-link formation. Other researchers have
demonstrated that lens GR activity decreases with aging and
cataract formation [23]. Decrease of the GR activity may be
responsible for the low levels of free GSH in the cataractous
lenses. Possible causes of reduction of GR activity in the lens
during the development of cataract are the chronic exposure
to UVA light of the solar spectrum [24] and/or oxidative
modiﬁcation of enzymes by reactive oxygen radicals [25].
Linetsky and associates have suggested that chronic exposure
to UVA light in the development of cataract leads to
absorption of UVA light by ﬂavin adenine dinucleotide
(FAD) and coenzyme GR, which causes its photolysis and
inactivation of the enzyme glutathione reductase [24]. Other
authors suggest that a possible cause of the decreased activity
of glutathione reductase in cataract lenses is thiol oxidation
of the enzyme and an unfolding of enzymes [23].
Among our patients, a signiﬁcantly higher concentration
of total thiol groups was measured in lenses with incipient
(102.5 ± 25.5μmol/g) compared to lenses with mature
(54.8 ± 19.7μmol/g) (P<0.001) age-related cataract.
During the development of cataract, the amount of thiol
groups in the crystalline is being progressively reduced, as a
result of “unfolding” macromolecular chains of protein and
consequent oxidation of disulﬁde bonds. This reduction of
the concentration of protein-SH groups in the older lenses
depends on the availability of GSH and GSH-dependent
enzymes.
Membrane protein thiol groups of lens epithelial cells,
which are important for the regulation of ion transport, are
highly susceptible to oxidative attack, especially when the
level of intracellular GSH is decreased. Optimal membrane
function of lens epithelial cells depends on the reduced
state of protein-SH groups. The loss of membrane-SH
groups and consequent increase of membrane permeability,
which occurs as a consequence of oxidative damage, are
probably involved in the development of cataract. Oxidation
of membrane thiol groups of lenses leads to disruption of
active transport through the membrane, which is accom-
panied by intracellular changes. Disturbed active transport
leads to reduced levels of vitamin C in the lens. Studies
have conﬁrmed that ascorbate levels in human lenses with
the development of age-related cataracts are reduced [26],
and concentration of dehydrascorbate is increased [11].
Measured concentrations of total vitamin C and ascorbic
acid concentrations in our patients are consistent with these
tests. With progression of cataracts, from the incipient to
mature, the concentration of total vitamin C and ascorbic
acid is progressively reduced (Table 1), while the amount of
dehydroascorbicaciddoesnotchangesigniﬁcantly.However,
the ratio of DHA/AA is more important for estimating the
participationofvitaminCinantioxidantprotectionoflenses
than the concentration of total vitamin C. In the lenses of
ourpatients,thehigherconcentrationofDHAwasmeasured
compared to concentration of AA, regardless of the maturity
degree of the cataract.
Accordingly, the concentration ratio of DHA/AA was
higher in mature cataracts, where the measured concentra-
tion of AA is signiﬁcantly lower than in the incipient cataract
(Table 1). Higher concentration ratio of DHA/AA indicates
the presence of oxidative stress. Higher concentration of
dehydroascorbate in lenses of our patients can be explained
by the inability of its reduction in ascorbic acid due to
decreasedamountofreducedglutathione,whichismeasured
in the test lenses (Table 1).
It is possible that low level of reduced glutathione in the
lens leads to an increase of degradation products of ascor-
bic acid (dehydroascorbic acid (DHA), 2.3-diketogulonic
acid, L-xylosone, and L-threose). Some believe that theseOxidative Medicine and Cellular Longevity 7
intermediate potential agents modiﬁcations of lens proteins
are even more potent than those of glucose [27], and that
modiﬁcation of crystalline lens by these products leads to
their aggregation and precipitation [11]. In experimental
conditions, exposure of rabbit lenses to dehydroascorbic
acid in conditions of suppressed reduction of GSSG by
glutathione reductase leads to lens opaciﬁcation few hours
after the experiment started [28].
Experiments on isolated proteins showed that oxidation
products of ascorbate can form cross-link with crystalline
lens, producing molecules of high molecular weight, which
cause light scattering typical for cataract [14]. It is assumed
that similar modiﬁcation of lens proteins occurs in vivo
during the development of age-related cataract [29]. How-
ever, in balanced physiological condition of prooxidant and
antioxidant, there is a small possibility that some oxidation
products of ascorbate are to be involved as cataractogenic
factors, because of their short half-life and rapid reduction
in the presence of reduced glutathione. Decreased reduction
of DHA to ascorbic acid and consequent accumulation of
DHA in the lens are also contributed with reduced activity
of enzymes of dehydroascorbate reductase, due to lower
concentration of available reduced glutathione, especially in
the nucleus of the lens due to formation of some sort of
transport barrier [30]. Modiﬁcation of lens proteins can
accelerate the creation of a barrier between metabolically
active cortex and inert nucleus [31], that prevents the
diﬀusion of antioxidant molecules to the nuclear part, so
the center of the lens is more exposed to oxidation, which
is important for the development of nuclear cataract [32].
This probably causes the decrease of GSH concentration in
the nucleus of the lens, so the response to oxidative damage
in this part of the lens is reduced [31].
FRAL analysis was used to assess total antioxidant ability
of the lens with age-related cataract. This analysis examines
ferric-reducing ability of the sample and it is based on
ability of antioxidant to reduce Fe+3 to Fe+2. Signiﬁcantly
higher ferric-reducing ability is found in lenses of patient
with incipient cataract (P<0.001) compared to lenses
with mature cataract(Table 1), then the lenses with posterior
subcapsular cataract (P<0.001) are compared to lenses with
corticonuclear cataract (Table 2). In lenses of the patients
with mature age-related cataract, signiﬁcantly higher values
of FRAL analysis were measured in lenses where the cataract
started as posterior subcapsular (P<0.05) than in lenses
where the cataract started as corticonuclear (Table 3). These
results are consistent with the measured concentrations of
individual antioxidants in lenses with age-related cataract.
In lenses with mature cataract, a smaller amount of reduced
glutathione, lower concentration of total thiol groups, and
lower concentration of total vitamin C and ascorbate were
measured, compared to lenses of patients with incipient
cataract (Table 1). Consequently, the total antioxidant ability
of lenses with mature cataract is lower compared to lenses
with incipient cataract (Table 1). With the development and
the progression of cataract towards total (mature) cataract,
comes the consumption and exhaustion of antioxidants, and
the activity of antioxidant enzymes is reduced, as a result of
changingofstructureofenzymemolecules,and/orasaresult
of decreased synthesis of enzymes, or as a result of reducing
the amount of reduced glutathione, which is necessary for
the activity of glutathione-dependent enzymes. Signiﬁcantly
lower ferric-reducing ability of lenses in which the nuclear
part is aﬀected by cataract changes (Tables 2 and 3) shows
thehighernucleussensibilitytooxidativedamagescompared
to cortex of the lens, probably because of the location, struc-
ture, and physiological inertness in relation to epithelium of
cortical parts.
5. Conclusion
The concentration of antioxidants decreases in lenses with
the progression of cataract towards mature, whereby the
lowest total antioxidant activity was detected in cataracts
with nuclear component. The highest concentration of
dehydroascorbic acid and redox balance of DHA/AA was
measured in mature cataracts, which started as cortical
nuclear. Timely removal of DHA from the lens is important
because of its potential toxicity as an oxidant and/or its
degradation products. For the reduction of DHA to AA, it
is very important to maintain activities of glutathione/redox
cycles in the lens, which prevents the accumulation of DHA
and prevents lens clouding. Also, the increase of the current
concentration of DHA/AA redox balance can be an indicator
of oxidative stress.
References
[1] H.R.Taylor,S.K.West,F.S.Rosenthaletal.,“Eﬀectofultravi-
olet radiation on cataract formation,” New England Journal of
Medicine, vol. 319, no. 22, pp. 1429–1433, 1988.
[2] C. Delcourt, I. Carri` ere, A. Ponton-Sanchez, A. Lacroux,
M. J. Covacho, and L. Papoz, “Light exposure and the risk
of cortical, nuclear, and posterior subcapsular cataracts: the
Pathologies Oculaires Liees a l’age (POLA) study,” Archives of
Ophthalmology, vol. 118, no. 3, pp. 385–392, 2000.
[3] R. Kannan, A. Stolz, Q. Ji, P. D. Prasad, and V. Ganapathy,
“Vitamin C transport in human lens epithelial cells: evidence
forthepresenceofSVCT2,”ExperimentalEyeResearch,vol.73,
no. 2, pp. 159–165, 2001.
[4] D. L. Garland, “Ascorbic acid and the eye,” American Journal
of Clinical Nutrition, vol. 54, no. 6, pp. 1198S–1202S, 1991.
[5] F. J. Giblin, “Glutathione: a vital lens antioxidant,” Journal of
Ocular Pharmacology and Therapeutics, vol. 16, no. 2, pp. 121–
135, 2000.
[6] M. F. Lou, “Thiol regulation in the lens,” Journal of Ocular
Pharmacology and Therapeutics, vol. 16, no. 2, pp. 137–148,
2000.
[7] A. Spector, W. Ma, R. R. Wang, Y. Yang, and Y. S. Ho, “The
contribution of GSH peroxidase-1, catalase and GSH to the
degradation of H2O2 by the mouse lens,” Experimental Eye
Research, vol. 64, no. 3, pp. 477–485, 1997.
[8] J. Sedlak and R. H. Lindsay, “Estimation of total, protein-
bound, and nonprotein sulfhydryl groups in tissue with
Ellman’s reagent,” Analytical Biochemistry,v o l .2 5 ,n o .C ,p p .
192–205, 1968.
[9] D. B. McCormic, “Vitamins,” in Textbook of Clinical Chem-
istry, N. W. Tietz, Ed., p. 927, WB Saunders Company, Phila-
delphia, Pa, USA, 1986.8 Oxidative Medicine and Cellular Longevity
[10] I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of
plasma(FRAP)asameasureof“antioxidantpower”:theFRAP
assay,”AnalyticalBiochemistry,vol.239,no.1,pp.70–76,1996.
[11] M. Linetsky, E. Shipova, R. Cheng, and B. J. Ortwerth,
“Glycation by ascorbic acid oxidation products leads to the
aggregation of lens proteins,” Biochimica et Biophysica Acta—
Molecular Basis of Disease, vol. 1782, no. 1, pp. 22–34, 2008.
[12] M. Balaji, K. Sasikala, and T. Ravindran, “Copper levels in
human mixed, nuclear brunescence, and posterior subcapsu-
lar cataract,” British Journal of Ophthalmology, vol. 76, no. 11,
pp. 668–669, 1992.
[13] B. Garner, M. J. Davies, and R. J. W. Truscott, “Formation of
hydroxyl radicals in the human lens is related to the severity of
nuclear cataract,” Experimental Eye Research,v o l .7 0 ,n o .1 ,p p .
81–88, 2000.
[14] R. H. Nagaraj and V. M. Monnier, “Protein modiﬁcation by
the degradation products of ascorbate: formation of a novel
pyrrole from the Maillard reaction of L-threose with pro-
teins,” Biochimica et Biophysica Acta—Protein Structure and
Molecular Enzymology, vol. 1253, no. 1, pp. 75–84, 1995.
[ 1 5 ]S .H .S l i g h t ,M .S .F e a t h e r ,a n dB .J .O r t w e r t h ,“ G l y c a t i o no f
lens proteins by the oxidation products of ascorbic acid,” Bio-
chimica et Biophysica Acta—Protein Structure and Molecular
Enzymology, vol. 1038, no. 3, pp. 367–374, 1990.
[16] S. P. Gartaganis, C. D. Georgakopoulos, N. E. Patsoukis, S.
S. Gotsis, V. S. Gartaganis, and C. D. Georgiou, “Glutathione
and lipid peroxide changes in pseudoexfoliation syndrome,”
Current Eye Research, vol. 30, no. 8, pp. 647–651, 2005.
[17] L. Zoric, S. Elek-Vlajic, M. Jovanovic et al., “Oxidative stress
intensity in lens and aqueous depending on age-related
cataract type and brunescense,” European Journal of Ophthal-
mology, vol. 18, no. 5, pp. 669–674, 2008.
[18] M. A. Babizhayev, “Failure to withstand oxidative stress in-
duced by phospholipid hydroperoxides as a possible cause of
the lens opacities in systemic diseases and ageing,” Biochimica
et Biophysica Acta—Molecular Basis of Disease, vol. 1315, no.
2, pp. 87–99, 1996.
[19] O. Donma, E. ¨ O .Y o r u l m a z ,H .P e k e l ,a n dN .S u y u g¨ ul, “Blood
and lens lipid peroxidation and antioxidant status in normal
individuals, senile and diabetic cataractous patients,” Current
Eye Research, vol. 25, no. 1, pp. 9–16, 2002.
[20] B. Kisic, D. Miric, L. Zoric, I. Dragojevic, and A. Stolic, “Role
of lipid peroxidation in pathogenesis of senile cataract,” Voj-
nosanitetski Pregled, vol. 66, no. 5, pp. 371–375, 2009.
[ 2 1 ]M .F .L o u ,J .E .D i c k e r s o nJ r . ,W .H .T u n g ,J .K .W o l f e ,a n dL .
T. Chylack Jr., “Correlation of nuclear color and opalescence
with protein S-thiolation in human lenses,” Experimental Eye
Research, vol. 68, no. 5, pp. 547–552, 1999.
[22] M. F. Lou and J. E. Dickerson Jr., “Protein-thiol mixed disul-
ﬁdes in human lens,” Experimental Eye Research, vol. 55, no. 6,
pp. 889–896, 1992.
[23] H. Yan, J. J. Harding, K. Xing, and M. F. Lou, “Revival of
glutathione reductase in human cataractous and clear lens
extracts by thioredoxin and thioredoxin reductase, in con-
junction with α-crystallin or thioltransferase,” Current Eye
Research, vol. 32, no. 5, pp. 455–463, 2007.
[24] M. D. Linetsky, J. M. W. Hill, V. G. Chemoganskiy, F. Hu, and
B. J. Ortwerth, “Studies on the mechanism of the UVA light-
dependent loss of glutathione reductase activity in human
lenses,”InvestigativeOphthalmologyandVisualScience,vol.44,
no. 9, pp. 3920–3926, 2003.
[25] T. Tabatabaie and R. A. Floyd, “Susceptibility of glutathione
peroxidase and glutathione reductase to oxidative damage
and the protective eﬀect of spin trapping agents,” Archives of
BiochemistryandBiophysics,vol.314,no.1,pp.112–119,1994.
[26] W. Huang, A. Koralewska-Mak´ ar, B. Bauer, and B. ˚ Akesson,
“Extracellular glutathione peroxidase and ascorbic acid in
aqueous humor and serum of patients operated on for
cataract,” Clinica Chimica Acta, vol. 261, no. 2, pp. 117–130,
1997.
[27] K. W. Lee, G. Simpson, and B. Ortwerth, “A systematic
approach to evaluate the modiﬁcation of lens proteins by gly-
cation-induced crosslinking,” Biochimica et Biophysica Acta—
Molecular Basis of Disease, vol. 1453, no. 1, pp. 141–151, 1999.
[28] H. Sasaki, F. J. Giblin, B. S. Winkler, B. Chakrapani, V. Lever-
enz, and S. Chu-Chen, “A protective role for glutathione-
dependent reduction of dehydroascorbic acid in lens epithe-
lium,” Investigative Ophthalmology and Visual Science, vol. 36,
no. 9, pp. 1804–1817, 1995.
[29] X. Fan, L. W. Reneker, M. E. Obrenovich et al., “Vitamin C
mediates chemical aging of lens crystallins by the Maillard
reaction in a humanized mouse model,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 103, no. 45, pp. 16912–16917, 2006.
[30] M. H. J. Sweeney and R. J. W. Truscott, “An impediment to
glutathionediﬀusioninoldernormalhumanlenses:apossible
precondition for nuclear cataract,” Experimental Eye Research,
vol. 67, no. 5, pp. 587–595, 1998.
[31] J. A. Vinson, “Oxidative stress in cataracts,” Pathophysiology,
vol. 13, no. 3, pp. 151–162, 2006.
[32] R. J. W. Truscott, “Age-related nuclear cataract—oxidation is
the key,” Experimental Eye Research, vol. 80, no. 5, pp. 709–
725, 2005.